Task: Answer the multiple-choice question.
Query: Which drug exhibits a -3.720% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: Cc1cc(C)c(C#N)c(Sc2nnnn2-c2ccccc2)n1
b: O=C(CCn1c(=S)[nH]c2ccccc2c1=O)N1CCOCC1
Answer: a. Cc1cc(C)c(C#N)c(Sc2nnnn2-c2ccccc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)c(C#N)c(Sc2nnnn2-c2ccccc2)n1
Cc1cc(C)c(C#N)c(Sc2nnnn2-c2ccccc2)n1
4,6-dimethyl-2-(1-phenyltetrazol-5-yl)sulfanylpyridine-3-carbonitrile